Titre :
  • Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study.
Auteur : Kaufman, Bella ; Trudeau, Maureen ; Awada, Ahmad ; Blackwell, Kimberly ; Bachelot, Thomas ; Salazar, Vanessa ; DeSilvio, Michelle ; Westlund, Ronald ; Zaks, Tal ; Spector, Neil ; Johnston, Stephen
Informations sur la publication : Lancet oncology, 10, 6, (page 581-588)
Statut de publication : Publié, 2009-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- genetics
Breast Neoplasms -- metabolism
Breast Neoplasms -- mortality
Female
Humans
Middle Aged
Quinazolines -- therapeutic use
Receptor, erbB-2 -- genetics
Receptor, erbB-2 -- metabolism
Recurrence
Skin Diseases -- pathology
Treatment Outcome
Note : Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1470-2045 
info:doi/10.1016/S1470-2045(09)70087-7
info:pii/S1470-2045(09)70087-7
info:pmid/19394894